In 2014 the U.S. Food and Drug Administration approved Gardasil 9 for use in males and females aged 9 through to 26 years. And as the US market for Gardasil declines there is a new customer base for this dangerous vaccine.
On October 5 2018 the FDA approved Gardasil 9 for use in women and men aged 27 through 45 years. This is a very strange move owing to the fact that for the last ten years the FDA had denied Merck’s request to expand the Gardasil market to adults. Continue reading
In the research for my book Gardasil: Fast-Tracked and Flawed
I discovered that although mainstream media remains silent about the problems emanating from this vaccination program, some doctors are reporting the adverse effects on young women’s health.
In the BMJ (British Medical Journal) Case Reports authors Deidre Little and Harvey Rodrick Grenville Ward of Australia reported the case of a patient with amenorrhoea who noticed that her usual regular menstrual cycle had changed, becoming irregular and then scant after Gardasil. Continue reading